Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

Objective: To explore the effects of exposure to subcutaneous (sc) interferon (IFN) beta-1a on efficacy in patients with relapsing–remitting multiple sclerosis (RRMS) enrolled in the PRISMS (Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) study. Meth...

Cijeli opis

Bibliografski detalji
Glavni autori: Bernard Uitdehaag, Cris Constantinescu, Peter Cornelisse, Douglas Jeffery, Ludwig Kappos, David Li, Magnhild Sandberg-Wollheim, Anthony Traboulsee, Elisabetta Verdun, Victor Rivera
Format: Članak
Jezik:English
Izdano: SAGE Publishing 2011-01-01
Serija:Therapeutic Advances in Neurological Disorders
Online pristup:https://doi.org/10.1177/1756285610391693